Herceptin: A First Assault on Oncogenes that Launched a Revolution.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 31519311.
- Also identified by DOI 10.1016/j.cell.2019.08.027.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This year's Lasker Clinical Research Award honors H. Michael Shepard, Dennis J. Slamon, and Axel Ullrich for their invention of Herceptin, the first monoclonal antibody that blocks a cancer-causing protein, and for its development as a life-saving therapy for women with breast cancer.
Medical subject headings
- Antineoplastic Agents, Immunological
- Breast Neoplasms
- Genes, erbB-2
- Molecular Targeted Therapy
- Trastuzumab